Linden Advisors »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Linden Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Linden Advisors from 13F filings

Historical chart of Linden Advisors investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Linden Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Linden Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $77B 82M 937.06